{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:00:00Z","timestamp":1790164800783,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13527-9","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:35:17Z","timestamp":1782920117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and kinetics of viral infections during the first 100\u2009days after pediatric hematopoietic stem cell transplantation at the Children\u2019s Hospital in Rabat"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohamed","family":"Hassaine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariame","family":"Lakhrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria El","family":"Kababri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Touyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghizlane El","family":"Amine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Zouaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aouatif El","family":"Arrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Kili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed El","family":"Khorassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual El","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Isfaoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Hessissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakima","family":"Kabbaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"13527_CR1","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.ejcped.2023.100131","volume":"2","author":"KK Rauwolf","year":"2023","unstructured":"Rauwolf KK, Pichler H. Virus infections after allogeneic stem cell transplantation in children. Review. EJC Paediatric Oncol. 2023, Dec;2:100131. https:\/\/doi.org\/10.1016\/j.ejcped.2023.100131.","journal-title":"EJC Paediatric Oncol"},{"issue":"6","key":"13527_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/bmt.2012.221","volume":"48","author":"P Hiwarkar","year":"2013","unstructured":"Hiwarkar P, Gaspar HB, Gilmour K, Jagani M, Chiesa R, Bennett-Rees N, et al. Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transpl. 2013, Jun;48(6):803\u201308. https:\/\/doi.org\/10.1038\/bmt.2012.221. Epub 2012 Nov 26. PMID: 23178547.","journal-title":"Bone Marrow Transpl"},{"key":"13527_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-9034-4_11","volume-title":"Principles and practice of transplant infectious diseases [internet]","author":"MR Pereira","year":"2019","unstructured":"Pereira MR, Pouch SM, Scully B. Infections in allogeneic stem cell transplantation. In: Safdar A, editor. Principles and practice of transplant infectious diseases [internet]. New York, NY: Springer New York; 2019. p. 209\u201326. Available from: 2025 Nov 6: http:\/\/link.springer.com\/10.1007\/978-1-4939-9034-4_11 ."},{"key":"13527_CR4","doi-asserted-by":"publisher","unstructured":"Yamada M, Sakamoto K, Tomizawa D, Ishikawa Y, Matsui T, Gocho Y, et al. A prospective viral monitoring study after pediatric allogeneic hematopoietic stem cell transplantation for malignant and nonmalignant diseases. Transplant Cellular Ther. 2021, Oct;27(10):.e872.1\u201328. https:\/\/doi.org\/10.1016\/j.jtct.2021.07.014.","DOI":"10.1016\/j.jtct.2021.07.014"},{"key":"13527_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TRRM.S278655","volume":"13","author":"B Rezzouk","year":"2021","unstructured":"Rezzouk B, Bouattar T, Belkadi B, Razine R, Bayahia R, Ouzeddoun N, et al. Characteristics and outcomes of cytomegalovirus infection in seropositive kidney transplant recipients in the era of antiviral prophylaxis with valacyclovir: a single-center study in Morocco. TRRM. 2021, Jan;13:1\u201313. https:\/\/doi.org\/10.2147\/TRRM.S278655.","journal-title":"TRRM"},{"issue":"3","key":"13527_CR6","doi-asserted-by":"publisher","first-page":"116967","DOI":"10.1016\/j.diagmicrobio.2025.116967","volume":"113","author":"A Zouaki","year":"2025","unstructured":"Zouaki A, Abidi K, Seffar M, Abouqal R, El Amine G, Dendane T, et al. Cytomegalovirus reactivation among immunocompetent patients hospitalized in medical intensive care: associated factors and consequences. Diagn Microbiol Infect DisDiagnostic Microbiol Infect Disease. 2025, Nov;113(3):116967. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116967.","journal-title":"Diagn Microbiol Infect DisDiagnostic Microbiol Infect Disease"},{"key":"13527_CR7","doi-asserted-by":"publisher","first-page":"1492367","DOI":"10.3389\/fimmu.2024.1492367","volume":"15","author":"G Ferrando","year":"2024","unstructured":"Ferrando G, Bagnasco F, Pierri F, Pestarino S, Dell\u2019orso G, Giardino S, et al. Epstein\u2013Barr virus reactivation in pediatric allogeneic stem cell transplant recipients: an 11-year experience on viral load and B lymphocyte monitoring strategy. Front Immunol. 2024, Oct, 25;15:1492367. https:\/\/doi.org\/10.3389\/fimmu.2024.1492367.","journal-title":"Front Immunol"},{"key":"13527_CR8","doi-asserted-by":"crossref","unstructured":"Sureda A, Corbacioglu S, Greco R, Kr\u00f6ger N, Carreras E, editors. The EBMT Handbook: hematopoietic cell transplantation and cellular therapies [internet]. Cham: Springer International Publishing; 2024. 2025 Nov 6]. : https:\/\/link.springer.com\/10.1007\/978-3-031-44080-9.","DOI":"10.1007\/978-3-031-44080-9"},{"key":"13527_CR9","doi-asserted-by":"publisher","unstructured":"Ljungman P, Alain S, Chemaly RF, Einsele H, Galaverna F, Hirsch HH, et al. Recommendations from the 10th European conference on infections in leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies. The Lancet Infect Dis. 2025, Aug;25(8):e451\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(25)00069-6.","DOI":"10.1016\/S1473-3099(25)00069-6"},{"issue":"25","key":"13527_CR10","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377(25):2433\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1706640.","journal-title":"N Engl J Med"},{"key":"13527_CR11","doi-asserted-by":"publisher","unstructured":"Groll AH, Danziger-Isakov L, Gefen A, Fraser CJ, Schulte JH, Bielorai B, etal.. Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study. Antimicrob Agents Chemother. 2025;69(10):e0042025. https:\/\/doi.org\/10.1128\/AAC.00420-25.","DOI":"10.1128\/AAC.00420-25"},{"issue":"3","key":"13527_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/cid\/ciae321","volume":"79","author":"P Ljungman","year":"2024","unstructured":"Ljungman P, Chemaly RF, Khawaya F, Alain S, Avery R, Badshah C, et al. Consensus Definitions of cytomegalovirus (CMV) infection and disease in transplant patients including resistant and refractory CMV for use in clinical trials: 2024 Update from the transplant associated virus infections Forum. Clin Infect Dis. 2024, Sept, 26;79(3):787\u201394. https:\/\/doi.org\/10.1093\/cid\/ciae321.","journal-title":"Clin Infect Dis"},{"key":"13527_CR13","doi-asserted-by":"publisher","first-page":"10273","DOI":"10.3389\/ti.2021.10273","volume":"35","author":"I Rodr\u00edguez-Goncer","year":"2022","unstructured":"Rodr\u00edguez-Goncer I, Ruiz-Ruig\u00f3mez M, L\u00f3pez-Medrano F, Trujillo H, Gonz\u00e1lez E, Polanco N, et al. Cytomegalovirus exposure and the risk of overall infection after kidney transplantation: a cohort study on the indirect effects attributable to viral replication. Transpl Int. 2022, Jan, 20;35:10273. https:\/\/doi.org\/10.3389\/ti.2021.10273.","journal-title":"Transpl Int"},{"key":"13527_CR14","doi-asserted-by":"crossref","unstructured":"Carreras E, Dufour C, Mohty M, Kr\u00f6ger N, editors.. The EBMT Handbook: hematopoietic stem cell transplantation and cellular therapies [Internet]. Cham: Springer International Publishing; 2019. 2025 Nov 4]. : http:\/\/link.springer.com\/10.1007\/978-3-030-02278-5.","DOI":"10.1007\/978-3-030-02278-5"},{"issue":"12","key":"13527_CR15","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.bbmt.2018.08.010","volume":"24","author":"DA Keesler","year":"2018","unstructured":"Keesler DA, St. Martin A, Bonfim C, Seber A, Zhang MJ, Eapen M. Bone marrow versus peripheral blood from unrelated donors for children and adolescents with acute leukemia. Biol Blood Marrow Transplant. 2018, Dec;24(12):2487\u201392. https:\/\/doi.org\/10.1016\/j.bbmt.2018.08.010.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"13527_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00432-025-06138-5","volume":"151","author":"V Apolito","year":"2025","unstructured":"Apolito V, Ceolin V, Spadea M, Vitale R, Barone M, Tomatis A, et al. Cyclosporine plus methotrexate versus cyclosporine alone for graft-versus-host disease prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation from an HLA-identical sibling. J Cancer Res Clin Oncol. 2025, Feb, 25;151(2):91. https:\/\/doi.org\/10.1007\/s00432-025-06138-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"13527_CR17","doi-asserted-by":"publisher","unstructured":"D\u00fcver F, Wei\u00dfbrich B, Eyrich M, W\u00f6lfl M, Schlegel PG, Wiegering V. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients \u2013 a single center 11-year analysis. PLoS One. 2020, Feb, 4;15(2):e0228451. https:\/\/doi.org\/10.1371\/journal.pone.0228451. Boussiotis, VA, editor..","DOI":"10.1371\/journal.pone.0228451"},{"issue":"21","key":"13527_CR18","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.3390\/diagnostics14212461","volume":"14","author":"G Ferrando","year":"2024","unstructured":"Ferrando G, Bagnasco F, Giardino S, Pierri F, Pestarino S, Di Marco E, et al. Monitoring and management of cytomegalovirus reactivations after allogeneic hematopoietic stem cell transplantation in children: experience from a single pediatric center. Diagnostics. 2024, Nov, 3;14(21):2461. https:\/\/doi.org\/10.3390\/diagnostics14212461.","journal-title":"Diagnostics"},{"key":"13527_CR19","doi-asserted-by":"publisher","first-page":"1518275","DOI":"10.3389\/fmicb.2025.1518275","volume":"16","author":"R Lin","year":"2025","unstructured":"Lin R, Wu J, Liu Q. Epidemiology, clinical outcomes, and treatment patterns of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in China: a scoping review and meta-analysis. Front MicrobiolFront. Microbiol. 2025, Apr, 3;16:1518275. https:\/\/doi.org\/10.3389\/fmicb.2025.1518275.","journal-title":"Front MicrobiolFront. Microbiol"},{"key":"13527_CR20","doi-asserted-by":"publisher","first-page":"732826","DOI":"10.3389\/fimmu.2021.732826","volume":"12","author":"XH Luo","year":"2021","unstructured":"Luo XH, Zhu Y, Chen YT, Shui LP, Liu L. CMV infection and CMV-Specific immune reconstitution following haploidentical stem cell transplantation: an Update. Front Immunol. 2021, Oct, 28;12:732826. https:\/\/doi.org\/10.3389\/fimmu.2021.732826.","journal-title":"Front Immunol"},{"issue":"3","key":"13527_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40506-021-00253-w","volume":"13","author":"N Jakharia","year":"2021","unstructured":"Jakharia N, Howard D, Riedel DJ. CMV infection in hematopoietic stem cell transplantation: prevention and treatment strategies. Curr Treat Options Infect Dis. 2021, July, 21;13(3):123\u201340. https:\/\/doi.org\/10.1007\/s40506-021-00253-w.","journal-title":"Curr Treat Options Infect Dis"},{"key":"13527_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-1-4939-9034-4_11","volume-title":"Principles and practice of transplant infectious diseases [internet]","author":"MR Pereira","year":"2019","unstructured":"Pereira MR, Pouch SM, Scully B. Infections in allogeneic stem cell transplantation. In: Safdar A, editor. Principles and practice of transplant infectious diseases [internet]. New York, NY: Springer New York; 2019. p. 209\u201326. Available from: 2025 Nov 10: https:\/\/doi.org\/http:\/\/link.springer.com\/10.1007\/978-1-4939-9034-4_11 ."},{"key":"13527_CR23","unstructured":"Mardani M, Abolghasemi S, Shabani S, Tavakoli F, Saeedi A, Parkhideh S, et al. The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Iran J Microbiol [Internet]. 2020 Dec 30. https:\/\/ec2-18-184-16-47.eu-central-1.compute.amazonaws.com\/index.php\/IJM\/article\/view\/5040. 2025 Nov 10]; ."},{"issue":"5","key":"13527_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/infdis\/jiad386","volume":"229","author":"A Sadowska-Klasa","year":"2024","unstructured":"Sadowska-Klasa A, Leisenring WM, Limaye AP, Boeckh M. Cytomegalovirus viral load threshold to guide preemptive therapy in hematopoietic cell transplant recipients: correlation with cytomegalovirus disease. The J Infect Dis. 2024, May, 15;229(5):1435\u201339. https:\/\/doi.org\/10.1093\/infdis\/jiad386.","journal-title":"The J Infect Dis"},{"key":"13527_CR25","doi-asserted-by":"publisher","first-page":"1302627","DOI":"10.3389\/fimmu.2023.1302627","volume":"14","author":"S Dobrer","year":"2024","unstructured":"Dobrer S, Sherwood KR, Hirji I, Lan J, Gill J, Matic N, et al. Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation. Front Immunol. 2024, Jan, 31;14:1302627. https:\/\/doi.org\/10.3389\/fimmu.2023.1302627.","journal-title":"Front Immunol"},{"issue":"1","key":"13527_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","volume":"7","author":"J Styczynski","year":"2018","unstructured":"Styczynski J. Who is the patient at risk of CMV recurrence: a review of the Current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018, Mar;7(1):1\u201316. https:\/\/doi.org\/10.1007\/s40121-017-0180-z.","journal-title":"Infect Dis Ther"},{"issue":"11","key":"13527_CR27","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3390\/ijms20112666","volume":"20","author":"SY Cho","year":"2019","unstructured":"Cho SY, Lee DG, Kim HJ. Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy. IJMS. 2019, May, 30;20(11):2666. https:\/\/doi.org\/10.3390\/ijms20112666.","journal-title":"IJMS"},{"key":"13527_CR28","doi-asserted-by":"publisher","unstructured":"Heston SM, Young RR, Tanaka JS, Jenkins K, Vinesett R, Saccoccio FM, et al. Risk factors for CMV viremia and treatment-associated adverse events among pediatric hematopoietic stem cell transplant recipients. Open Forum Infect Dis. 2022, Feb, 1;9(2):ofab639. https:\/\/doi.org\/10.1093\/ofid\/ofab639.","DOI":"10.1093\/ofid\/ofab639"},{"issue":"3","key":"13527_CR29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00277-021-04428-9","volume":"100","author":"M Ko\u0142odziejczak","year":"2021","unstructured":"on behalf of Infectious Diseases Working Party, European Society for Blood and Marrow Transplantation, Ko\u0142odziejczak M, Gil L, De La Camara R, Styczy\u0144ski J. Impact of donor and recipient Epstein-Barr virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Ann Hematol. 2021, Mar;100(3):763\u201377. https:\/\/doi.org\/10.1007\/s00277-021-04428-9.","journal-title":"Ann Hematol"},{"issue":"3","key":"13527_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/pathogens14030236","volume":"14","author":"M Peras","year":"2025","unstructured":"Peras M, Bili\u0107 E, Marekovi\u0107 I. Recent insights into the pathogenesis, Diagnostics, and treatment of BK virus infections in children after hematopoietic stem cell transplantation. Pathogens. 2025, Feb, 28;14(3):236. https:\/\/doi.org\/10.3390\/pathogens14030236.","journal-title":"Pathogens"},{"key":"13527_CR31","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.3389\/fmicb.2018.03294","volume":"9","author":"C Pochon","year":"2019","unstructured":"Pochon C, Voigt S. Respiratory virus infections in hematopoietic cell transplant recipients. Front Microbiol. 2019, Jan, 9;9:3294. https:\/\/doi.org\/10.3389\/fmicb.2018.03294.","journal-title":"Front MicrobiolFront. Microbiol"},{"issue":"1","key":"13527_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3346\/jkms.2013.28.1.36","volume":"28","author":"JH Choi","year":"2013","unstructured":"Choi JH, Choi EH, Kang HJ, Park KD, Park SS, Shin HY, et al. Respiratory viral infections after hematopoietic stem cell transplantation in children. J Korean Med Sci. 2013;28(1):36. https:\/\/doi.org\/10.3346\/jkms.2013.28.1.36.","journal-title":"J Korean Med Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13527-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13527-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13527-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:03:28Z","timestamp":1790161408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13527-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13527"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13527-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Comit\u00e9 d\u2019\u00c9thique de la Recherche Biom\u00e9dicale (CERB) of the Faculty of Medicine and Pharmacy of Rabat (FMPR) under approval number 233\u201325. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki (World Medical Association) and its later amendments. Written informed consent was obtained from all participants. For pediatric patients, written informed consent was obtained from parents or legal guardians, and assent was obtained from the children when appropriate.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1699"}}